India's pharmaceutical sector benefits from US tariff exemptions, highlighting the global importance of its generic medicines. This decision strengthens India-US trade relations an...
Sun Pharma, India's leading drug maker, appoints Aalok Shanghvi as COO, signaling a strong succession plan and commitment to future growth under the guidance of the next generation...
Granules India Ltd reports a 6% drop in Q3 PAT to Rs 117.6 crore due to the temporary closure of its Gagillapur facility following USFDA observations, impacting revenues and profit...
